NurseNest
Sign InStart Free
NurseNest
AboutPricingInstitutionsBlogToolsFeaturesEvidenceExams
Sign InStart Free
RNRPNNPMedicineAlliedNew GradAdmissionsMore Exams ▼
  1. Home
  2. /Pre-nursing
  3. /Lessons
  4. /Inflammation & Immune Response
Back to Modules

Inflammation & Immune Response

Loading progress…

Save your progress across devices

Guest access stays fully free. Create a free account to keep module completion and study preferences synced on every device. No paid subscription is required for Pre-Nursing.

Create free accountSign in

Your progress · Inflammation & Immune Response

Pre-Nursing stays free. Progress is optional.

0% of modules

Start your first module to build momentum and unlock personalized recommendations.

Suggested next in sequence: study-strategies

Stay in Pre-Nursing

  • Try the adaptive mini exam
  • Browse all modules
  • Target date & unsure pacing
  • Med math tools

Ready for exam-style prep

Paid NurseNest plans add full question banks, mocks, and pathway-scoped lessons once you are comfortable with the basics here.

  • Compare Plans
  • Browse exam lesson hubs
  • Explore NCLEX & RN/PN pathways

Set a likely route on the study planning page to personalize these links.

Focus on foundations here; we’ll keep exam prep one click away.

Inflammation & Wound Healing

Understand the inflammatory response from cellular mechanisms to clinical signs, differentiate acute from chronic inflammation, master inflammatory mediators and their pharmacologic targets, and learn the phases of wound healing.

Acute vs. Chronic Inflammation

Protective response vs. pathological process

Inflammation is a fundamental protective response to tissue injury or infection. Acute inflammation is rapid, self-limiting, and beneficial, it eliminates the threat and initiates repair. Chronic inflammation persists for weeks to years, causes ongoing tissue damage, and underlies many chronic diseases including atherosclerosis, rheumatoid arthritis, and cancer.

Acute Inflammation

Onset: Seconds to minutes. Duration: Hours to days. Primary cells: Neutrophils (first responders). Vascular changes: Vasodilation, increased permeability (exudate formation). Purpose: Eliminate the injurious agent, remove necrotic tissue, initiate repair. Outcomes: Complete resolution, abscess formation, or progression to chronic inflammation. Examples: Acute appendicitis, sprained ankle, bacterial pneumonia, surgical incision.

Chronic Inflammation

Onset: Gradual or follows unresolved acute inflammation. Duration: Weeks to years. Primary cells: Macrophages, lymphocytes, plasma cells. Tissue changes: Fibrosis, tissue destruction, angiogenesis occurring simultaneously. Purpose: Attempt to contain persistent threat, often causes more damage than the original insult. Examples: Rheumatoid arthritis, atherosclerosis, Crohn's disease, chronic hepatitis, tuberculosis.

The five cardinal signs of inflammation were first described by Celsus (rubor, calor, dolor, tumor) with functio laesa added by Virchow. Rubor (redness) results from vasodilation increasing blood flow to the area. Calor (heat) occurs from increased blood flow and metabolic activity. Dolor (pain) is caused by inflammatory mediators stimulating nerve endings and tissue swelling compressing nerves. Tumor (swelling) results from increased vascular permeability allowing fluid and proteins to leak into interstitial spaces. Functio laesa (loss of function) occurs as a protective mechanism, pain and swelling limit movement of the affected area, promoting healing.

Inflammatory Mediators & Pharmacologic Targets

Chemical signals that drive the inflammatory cascade

Understanding inflammatory mediators is essential because most anti-inflammatory medications work by targeting specific mediators or their pathways. Every NSAID, corticosteroid, antihistamine, and biologic drug connects back to these chemical signals.

Inflammatory mediators are chemical signals that coordinate the inflammatory response. Histamine (from mast cells) causes immediate vasodilation and increased vascular permeability, this is why antihistamines reduce swelling and itching. Prostaglandins (produced via the COX pathway) cause pain, fever, and prolonged vasodilation, NSAIDs work by inhibiting COX enzymes. Cytokines (IL-1, IL-6, TNF-alpha) are signaling proteins that recruit immune cells, induce fever via the hypothalamus, and can trigger systemic inflammatory response syndrome (SIRS) when overproduced. Complement proteins create membrane attack complexes that lyse pathogens. Leukotrienes cause bronchospasm and are involved in asthma pathophysiology.

Fever Physiology & Immune Regulation

Understanding fever as a regulated immune response

Fever is not a malfunction, it is a deliberate upward resetting of the hypothalamic thermostat in response to pyrogens. It enhances immune function but can become dangerous at extreme levels. Understanding fever physiology helps nurses make evidence-based decisions about when to treat fever and when to let it serve its protective role.

Fever Mechanism

Exogenous pyrogens (bacteria, viruses) stimulate macrophages to release endogenous pyrogens (IL-1, IL-6, TNF-α). These act on the hypothalamus to increase prostaglandin E2 (PGE2) production, which raises the thermostat set point. The body then generates heat through shivering and vasoconstriction (chills) until the new set point is reached. Antipyretics (acetaminophen, NSAIDs) lower fever by inhibiting PGE2 synthesis, they reset the thermostat back to normal, causing vasodilation and sweating (defervescence).

Immune Overreaction vs. Immunosuppression

Overreaction (Hypersensitivity): The immune system attacks harmless substances (allergies, Type I), self-tissues (autoimmune diseases, Type II/III), or causes excessive cell-mediated responses (contact dermatitis, Type IV). In severe cases, systemic overreaction causes anaphylaxis or cytokine storm. Immunosuppression: Inadequate immune response, from HIV/AIDS, chemotherapy, corticosteroids, malnutrition, or extremes of age. Increases susceptibility to opportunistic infections. Both extremes require nursing vigilance for different complications.

Wound Healing Phases

From hemostasis through remodeling

Wound healing is a complex, overlapping process that depends on adequate nutrition (especially protein and vitamin C), oxygenation, moisture balance, and absence of infection. Nurses play a critical role in optimizing healing conditions and recognizing signs of impaired healing.

Wound healing proceeds through four overlapping phases. Hemostasis (seconds to hours): vasoconstriction, platelet plug formation, fibrin clot stabilization, stops bleeding. Inflammatory phase (1-6 days): neutrophils arrive first (within hours) to phagocytize bacteria, followed by macrophages (24-48 hours) that clear debris and release growth factors. Proliferative phase (4-21 days): fibroblasts produce collagen, angiogenesis creates new blood vessels, granulation tissue fills the wound, and epithelial cells migrate across the wound surface. Remodeling phase (21 days to 2 years): collagen reorganizes along stress lines, scar tissue matures and strengthens (reaching maximum 80% of original skin strength), and excess vasculature regresses.

Wound Healing — Advanced Clinical Implications

Assessment, impairment factors, classification, and MEASURE framework

Advanced wound assessment goes beyond identifying the healing phase. Nurses must classify wounds, identify factors impairing healing, differentiate healing from infected tissue, and communicate findings using standardized frameworks.

Wound Classification by Contamination Level

Class I — Clean: Elective surgery, uninfected, no entry into respiratory/GI/GU tract. Lowest infection risk (<2%). Examples: orthopedic joint replacement, thyroidectomy. Class II — Clean-Contaminated: GI, GU, or respiratory tract entered under controlled conditions without unusual contamination. Examples: elective colorectal surgery, cholecystectomy. Infection risk: 10%. Class III — Contaminated: Open traumatic wound, major break in sterile technique, spillage from hollow viscus, chronic open wounds. Examples: penetrating trauma, accidental enterotomy. Infection risk: 20%. Class IV — Dirty/Infected: Pre-existing infection or perforated viscus. Old traumatic wounds with devitalized tissue, fecal contamination. Examples: ruptured appendix, perforated diverticulitis. Infection risk: >40%. Wound classification drives surgical prophylaxis decisions and post-operative infection monitoring intensity.

Factors That Impair Wound Healing

Infection: Competing bacteria redirect immune resources, produce toxins that destroy new tissue, and prolong the inflammatory phase. The wound cannot progress to proliferation until the infection is controlled. Malnutrition: Protein deficiency impairs collagen synthesis (fibroblasts need amino acids); vitamin C deficiency directly impairs collagen cross-linking (scurvy); zinc deficiency impairs cell proliferation and immune function. Diabetes mellitus: Triple impairment — (1) microvascular disease reduces oxygen delivery; (2) neuropathy eliminates protective pain sensation, allowing unnoticed trauma; (3) hyperglycemia impairs neutrophil and macrophage function, reduces opsonization. Corticosteroids: Suppress the inflammatory phase (phases 2 and 3 depend on inflammation), reduce fibroblast proliferation, impair collagen synthesis, and suppress the immune response. Patients on chronic steroids have fragile, poorly healing wounds. Smoking: Nicotine causes vasoconstriction → tissue hypoxia; carbon monoxide binds hemoglobin, reducing O₂ delivery; smoking impairs neutrophil chemotaxis and reduces tissue oxygenation at wound margins. Dehydration: Reduces tissue perfusion and oxygen delivery to healing wound. Obesity: Adipose tissue is poorly vascularized, creating areas of ischemia; increased tension on wound edges; impaired immune function in adipose tissue. Anemia: Hemoglobin carries O₂ — anemia reduces oxygen delivery to the healing wound, which requires elevated metabolic activity and O₂ consumption.

Wound Tissue Types and What They Mean

Granulation tissue (red/pink, moist, bumpy): Healthy new tissue — the wound is in the proliferative phase and healing is progressing. Do not disturb or debride. Protect with moist dressing. Slough (yellow/tan, moist, stringy): Non-viable fibrinous debris — must be removed (debridement) for wound to heal. Presence indicates the wound is in a prolonged inflammatory phase. Eschar (black, hard or leathery): Dry, desiccated necrotic tissue — must generally be debrided. Exception: stable dry eschar on heel wounds in patients with poor perfusion — leave intact (risk of debridement creating a larger wound in ischemic tissue). Epithelial tissue (pink/white, shiny, migratory): New skin migrating across the wound surface — healing is nearly complete. Protect from disruption. Tunneling: A channel extending from the wound into surrounding tissue — indicates undermining, often from shear forces in pressure injuries. Measure depth with a Q-tip and document direction (o'clock position).

Four Wound Healing Phases — Nursing Implications Summary

Fever — Mechanisms, Types, and Nursing Management

Pathophysiology, clinical patterns, hyperthermia vs fever, and evidence-based management

Fever is one of the most common clinical findings in nursing practice. Distinguishing fever from hyperthermia, recognizing the different fever patterns, and understanding when to treat versus observe requires a solid understanding of the underlying mechanisms.

Fever Pathophysiology — The Pyrogen Cascade

Step 1: Exogenous pyrogens (LPS from gram-negative bacteria cell walls, viral antigens, fungal components, drugs, antigen-antibody complexes) enter the systemic circulation. Step 2: Pattern recognition receptors (TLRs) on macrophages and monocytes detect exogenous pyrogens → macrophages release endogenous pyrogens: interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Step 3: Endogenous pyrogens cross the blood-brain barrier (or act at the circumventricular organs) → stimulate COX-2 in the anterior hypothalamus → increased prostaglandin E2 (PGE2) synthesis. Step 4: PGE2 acts on the preoptic area of the anterior hypothalamus → the thermostat set-point is raised. Step 5: The body generates heat to reach the new set-point: peripheral vasoconstriction (reduces heat loss), shivering (generates heat), behavioral changes (feeling cold, seeking warmth = "chills"). Step 6: Once core temperature reaches the new set-point, shivering stops and the patient feels hot. Antipyretics (acetaminophen, ibuprofen, aspirin) inhibit COX → reduce PGE2 → reset the thermostat → vasodilation + sweating = defervescence (fever "breaking").

Fever vs. Hyperthermia — A Critical Distinction

Fever: The hypothalamic thermostat SET POINT is actively raised by endogenous pyrogens. The body is working as designed — it wants to be hot. The body regulates heat generation and retention to achieve the elevated set-point. Causes: infection, inflammation, malignancy, drug fever (any medication, especially antibiotics, phenytoin, quinidine), autoimmune disorders. Treatment: antipyretics work by lowering the set-point back toward normal. Hyperthermia: The thermostat set-point is NORMAL but the body cannot dissipate heat fast enough, or an abnormal process is generating excessive heat. The hypothalamus is NOT causing the temperature rise. Causes: heat stroke (exercise or environmental), malignant hyperthermia (autosomal dominant, triggered by volatile anesthetics or succinylcholine — massive calcium release from SR → uncontrolled muscle contraction → extreme temperature), neuroleptic malignant syndrome (NMS — dopamine antagonists trigger rigidity and hyperthermia), serotonin syndrome, anticholinergic poisoning. CRITICAL: Antipyretics DO NOT work in hyperthermia — they lower the set-point, but the set-point is not elevated. External cooling measures are required. Malignant hyperthermia treatment: dantrolene (blocks calcium release from sarcoplasmic reticulum) + active cooling.

Fever Patterns and Clinical Significance

Intermittent fever: Spikes to febrile levels at certain times of day and returns to NORMAL between spikes. Seen in: gram-negative bacteremia (classic), intra-abdominal abscess, certain malignancies. The pattern of spikes can suggest the source. Remittent fever: Temperature fluctuates but does NOT return to normal — always elevated, but with ups and downs. Seen in: typhoid fever, viral infections, endocarditis. Sustained/continuous fever: Temperature remains consistently elevated with little fluctuation (<1°C variation). Classic pattern in: typhoid fever (Widal's pattern), lobar pneumonia, Rocky Mountain spotted fever. Relapsing/undulant fever: Febrile periods lasting days to weeks, separated by afebrile intervals. Seen in: Borrelia (relapsing fever tick-borne illness), malaria (classic tertian/quartan periodicity), Hodgkin lymphoma (Pel-Ebstein fever). Fever of unknown origin (FUO): Temperature ≥38.3°C (101°F) on multiple occasions, lasting >3 weeks, without diagnosis after 3 days of in-hospital investigation or 3 outpatient visits.

Evidence-Based Nursing Management of Fever

Monitor trend, not just the number: A fever of 38.8°C that is declining is clinically different from one that is rising. Document trends. Fluid management: Fever increases insensible losses — 10–15% increase in fluid requirements per degree above normal. Ensure adequate oral/IV hydration. Antipyretics: Acetaminophen (preferred — less GI irritation, no antiplatelet effects) or ibuprofen. Treat for patient comfort, not reflexively. Fever in itself is not always harmful. External cooling: For patient comfort — cool cloths, room temperature adjustment. Tepid sponge bath (lukewarm water) is acceptable. Cold water or alcohol baths are CONTRAINDICATED — cold causes peripheral vasoconstriction, trapping heat inside and causing shivering (which generates more heat). Blood cultures BEFORE antibiotics: If infection is suspected and antibiotics will be given, obtain blood cultures before the first antibiotic dose — antibiotics within hours render cultures negative. Febrile seizure precautions in children: Febrile seizures occur in children 6 months to 6 years with rapid temperature rise — padded side rails, suction available, call light within reach, no restraints. Monitoring: Vital signs q4h (tachycardia accompanies fever at ~10 bpm per 1°C). Monitor SpO2 (increased metabolic demand increases O₂ consumption).

When Fever Is Protective vs. When Treatment Is Necessary

Fever serves immunological functions that are beneficial in most circumstances: (1) Elevated temperatures impair replication efficiency of many pathogens — viruses and bacteria replicate optimally at 37°C; at 39–40°C, their replication rates drop significantly. (2) Fever activates immune cells — neutrophil and macrophage function is enhanced, and T-cell proliferation increases at higher temperatures. (3) Higher temperatures increase the effectiveness of many antibiotics. Treatment of fever is appropriate for: patient comfort (subjective distress, headache, myalgias), temperatures >40–41°C that risk febrile seizures, CNS complications, or myocardial demand, and patients with pre-existing cardiac disease where tachycardia is poorly tolerated. Fever should NOT be automatically treated simply because it is present — it may be doing beneficial work. Antipyretics treat the symptom, not the underlying cause.

Systemic Inflammatory Response and Clinical Conditions

SIRS, anaphylaxis, autoimmunity, and cytokine storm

When inflammatory processes escape local control, systemic syndromes emerge. Understanding SIRS, anaphylaxis, autoimmune conditions, and cytokine storm prepares nurses to recognize life-threatening inflammatory emergencies and prioritize interventions.

SIRS — Systemic Inflammatory Response Syndrome

SIRS criteria: 2 or more of the following: (1) Temperature >38°C or <36°C; (2) Heart rate >90 bpm; (3) Respiratory rate >20/min OR PaCO₂ <32 mmHg (hyperventilating); (4) WBC >12,000/mm³ or <4,000/mm³ or >10% bands (immature neutrophils). Critical distinction: SIRS can occur WITHOUT infection. Sterile causes of SIRS: trauma (severe injury releases DAMPs — damage-associated molecular patterns, the body's endogenous danger signals), burns (massive tissue necrosis), pancreatitis (pancreatic enzyme auto-digestion), major surgery, ischemia-reperfusion injury. SIRS + presumed or documented infection = Sepsis (Sepsis-3 definition: life-threatening organ dysfunction caused by dysregulated host response to infection). Nursing priorities: recognize SIRS early, assess for infection source, obtain cultures before antibiotics, monitor for organ dysfunction (mental status, urine output, creatinine, lactate).

Anaphylaxis — Systemic Type I Hypersensitivity Reaction

Mechanism: IgE-mediated mast cell and basophil degranulation → massive simultaneous release of histamine, leukotrienes, prostaglandins, and platelet-activating factor → distributive shock (massive vasodilation → ↓ SVR → hypotension), bronchospasm (wheezing, dyspnea), and mucosal edema (urticaria, angioedema, laryngeal edema). Onset: seconds to 30 minutes after exposure. Most common triggers: antibiotics (especially penicillin/beta-lactams — most common drug cause), peanuts and tree nuts, shellfish, bee/wasp stings, latex, iodinated contrast dye, aspirin/NSAIDs. Clinical presentation: urticaria (hives), flushing, pruritus, angioedema (lip/tongue swelling), bronchospasm (wheezing, stridor), hypotension, tachycardia, dizziness/syncope, GI cramping, feeling of impending doom. Treatment priority — EPINEPHRINE FIRST: IM epinephrine 0.3–0.5 mg (adult) into the anterolateral thigh (auto-injector or drawn up). This is the ONLY first-line treatment. Epinephrine reverses vasodilation, reduces bronchospasm, and reduces further mast cell degranulation. Diphenhydramine (Benadryl) and corticosteroids are SECONDARY — they do NOT reverse the immediate life-threatening components. DO NOT delay epinephrine to give antihistamines. Post-reaction: observe minimum 4–6 hours for biphasic reaction (second anaphylactic episode can occur 1–72 hours after initial reaction without re-exposure). Prescribe epinephrine auto-injector and refer to allergist.

Autoimmune Inflammatory Conditions

Rheumatoid Arthritis (RA): Chronic Type III/IV hypersensitivity. Activated T cells and autoantibodies (RF, anti-CCP) drive synovial inflammation → pannus formation (invasive synovial tissue) → progressive cartilage and bone destruction. Bilateral symmetric joint involvement (MCP, PIP joints — not DIP), morning stiffness >1 hour. Systemic manifestations: nodules, interstitial lung disease, accelerated atherosclerosis. Treatment: DMARDs (methotrexate), biologics (TNF-α inhibitors — infliximab, adalimumab; IL-6 inhibitors — tocilizumab). Systemic Lupus Erythematosus (SLE): Multi-organ autoimmune disease. Anti-dsDNA and anti-Smith antibodies are specific markers. Complement activation causes tissue damage. Classic: butterfly (malar) rash across cheeks/nose, photosensitivity, oral ulcers, arthritis, nephritis (lupus nephritis — leading cause of morbidity), serositis, CNS involvement. Flares triggered by UV light, infections, stress, and estrogen. Inflammatory Bowel Disease (IBD): Crohn's disease — transmural (full wall thickness), granulomatous, can affect any part of GI tract (mouth to anus), "skip lesions," fistula formation, cobblestone appearance. Ulcerative colitis — mucosal/submucosal only, continuous lesions always starting at rectum and extending proximally, no fistulas, increased colorectal cancer risk.

Cytokine Storm — Dysregulated Systemic Inflammation

Cytokine storm is a severe, dysregulated, hyperinflammatory response characterized by massively elevated circulating cytokines (IL-6, IL-1, TNF-α, IL-10, interferons) causing widespread endothelial damage and multi-organ failure. Distinguished from normal protective inflammation by: loss of regulatory control (feedback inhibition fails), involvement of multiple cytokines simultaneously, effects disproportionate to the triggering stimulus, and progressive multi-organ involvement. Clinical contexts: severe COVID-19 (cytokine storm drives ARDS and multi-organ failure), secondary HLH (hemophagocytic lymphohistiocytosis — associated with viral infections, malignancies), CAR-T cell therapy complications (release syndrome), severe sepsis/septic shock. Clinical findings: fever, hypotension (distributive shock), tachycardia, respiratory failure, altered mental status, elevated ferritin (marker of macrophage activation), elevated CRP and IL-6, cytopenias. Treatment: immunosuppression (corticosteroids, tocilizumab — IL-6 receptor blockade) PLUS treatment of underlying trigger, organ support in ICU. Key distinction from sepsis: in cytokine storm, aggressive immunosuppression is appropriate; in sepsis from uncontrolled infection, immunosuppression alone can be fatal.

Systemic Inflammatory Conditions: Mechanisms and Nursing Priorities

Systemic Inflammatory Response Knowledge Check

1/4

A patient with acute pancreatitis has temperature 38.4°C, HR 102, RR 22, and WBC 14,500. This patient meets SIRS criteria. Given that pancreatitis caused this, what does this SIRS represent?

0/6 matched

components.interactiveLearning.terms

components.interactiveLearning.definitions

1/20

Which cells are the FIRST to arrive at an acute inflammatory site?

Comprehensive Inflammation & Wound Healing Final Quiz

1/10

A patient receiving general anesthesia develops a temperature of 42°C, generalized muscle rigidity, and extreme tachycardia. The anesthesiologist stops the procedure. This MOST likely represents: